Analysis of MS Patients Who Have Had Greater Than 60 Infusions of Natalizumab

Condition:   Multiple Sclerosis Intervention:   Drug: Natalizumab Sponsor:   Multiple Sclerosis Center of Northeastern New York Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials